These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 3004227)

  • 1. Coxsackievirus B-3 myocarditis. Identification of different pathogenic mechanisms in DBA/2 and Balb/c mice.
    Huber SA; Lodge PA
    Am J Pathol; 1986 Feb; 122(2):284-91. PubMed ID: 3004227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coxsackievirus B-3 myocarditis. Acute and chronic forms of the disease caused by different immunopathogenic mechanisms.
    Lodge PA; Herzum M; Olszewski J; Huber SA
    Am J Pathol; 1987 Sep; 128(3):455-63. PubMed ID: 2957924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coxsackievirus-induced myocarditis is dependent on distinct immunopathogenic responses in different strains of mice.
    Huber SA
    Lab Invest; 1997 May; 76(5):691-701. PubMed ID: 9166288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac injury in myocarditis induced by Coxsackievirus group B, type 3 in Balb/c mice is mediated by Lyt 2 + cytolytic lymphocytes.
    Guthrie M; Lodge PA; Huber SA
    Cell Immunol; 1984 Oct; 88(2):558-67. PubMed ID: 6091924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular immune mechanisms in Coxsackievirus group B, type 3 induced myocarditis in Balb/C mice.
    Huber SA; Job LP
    Adv Exp Med Biol; 1983; 161():491-508. PubMed ID: 6307010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variations in the susceptibility to Coxsackievirus B3-induced myocarditis among different strains of mice.
    Wolfgram LJ; Beisel KW; Herskowitz A; Rose NR
    J Immunol; 1986 Mar; 136(5):1846-52. PubMed ID: 3005402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T lymphocyte responses in CVB3-induced murine myocarditis.
    Huber S; Polgar J; Moraska A; Cunningham M; Schwimmbeck P; Schultheiss P
    Scand J Infect Dis Suppl; 1993; 88():67-78. PubMed ID: 7685923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coxsackievirus B-3 myocarditis. T-cell autoimmunity to heart antigens is resistant to cyclosporin-A treatment.
    Estrin M; Smith C; Huber S
    Am J Pathol; 1986 Nov; 125(2):244-51. PubMed ID: 3024491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunopathogenesis of experimental Coxsackievirus induced myocarditis: role of autoimmunity.
    Huber SA; Lyden DC; Lodge PA
    Herz; 1985 Feb; 10(1):1-7. PubMed ID: 2984097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological mechanisms in experimental coxsackievirus B3 myocarditis in mice.
    Kishimoto C; Ochiai H; Sasayama S
    Jpn Circ J; 1991 Nov; 55(11):1144-8. PubMed ID: 1721094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modification of exercise-aggravated coxsackievirus B3 murine myocarditis by T lymphocyte suppression in an inbred model.
    Cabinian AE; Kiel RJ; Smith F; Ho KL; Khatib R; Reyes MP
    J Lab Clin Med; 1990 Apr; 115(4):454-62. PubMed ID: 2157783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coxsackievirus B-3 myocarditis in Balb/c mice. Evidence for autoimmunity to myocyte antigens.
    Huber SA; Lodge PA
    Am J Pathol; 1984 Jul; 116(1):21-9. PubMed ID: 6331168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigen-specific suppressor T cells prevent cardiac injury in Balb/c mice infected with a nonmyocarditic variant of coxsackievirus group B, type 3.
    Estrin M; Smith C; Huber S
    Am J Pathol; 1986 Dec; 125(3):578-84. PubMed ID: 2432792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coxsackievirus-induced disease. CD4+ cells initiate both myocarditis and pancreatitis in DBA/2 mice.
    Blay R; Simpson K; Leslie K; Huber S
    Am J Pathol; 1989 Nov; 135(5):899-907. PubMed ID: 2573284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Demonstration of suppressor cells in coxsackievirus group B, type 3 infected female Balb/c mice which prevent myocarditis.
    Job LP; Lyden DC; Huber SA
    Cell Immunol; 1986 Mar; 98(1):104-13. PubMed ID: 3017580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aggravation of coxsackievirus, group B, type 3-induced myocarditis and increase in cellular immunity to myocyte antigens in pregnant Balb/c mice and animals treated with progesterone.
    Lyden DC; Huber SA
    Cell Immunol; 1984 Sep; 87(2):462-72. PubMed ID: 6088088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The analysis of T cell receptor Vbeta gene usage of cytolytic T-lymphocytes in coxsackievirus B3-induced myocarditis].
    Wang YB; Hua YM; Shi XQ; Yang Y; Wei DP
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Jan; 37(1):80-3. PubMed ID: 16468649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variation in susceptibility of Balb/c mice to coxsackievirus group B type 3-induced myocarditis with age.
    Lyden D; Olszewski J; Huber S
    Cell Immunol; 1987 Apr; 105(2):332-9. PubMed ID: 3494528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decay-accelerating factor (CD55) promotes CD1d expression and Vgamma4+ T-cell activation in coxsackievirus B3-induced myocarditis.
    Huber S; Song WC; Sartini D
    Viral Immunol; 2006; 19(2):156-66. PubMed ID: 16817758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetics of Coxsackie B3 (CVB3) myocarditis.
    Van Houten N; Huber SA
    Eur Heart J; 1991 Aug; 12 Suppl D():108-12. PubMed ID: 1655440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.